Akumin (AKU) & The Competition Head to Head Contrast
Akumin (AKU) & The Competition Head to Head Contrast
Akumin presently has a consensus target price of $0.63, indicating a potential downside of 62.35%. As a group, "Medical laboratories" companies have a potential upside of 98.20%. Given Akumin's rivals stronger consensus rating and higher possible upside, analysts plainly believe Akumin has less favorable growth aspects than its rivals.Akumin (NASDAQ:AKU – Get Rating) is one of 46 publicly-traded companies in the "Medical laboratories" industry, but how does it compare to its rivals? We will compare Akumin to related businesses based on the strength of its institutional ownership, risk, earnings, dividends, analyst recommendations, profitability and valuation.
Akumin（纳斯达克股票代码：AKU -获得评级）是“医学实验室”行业的46家上市公司之一，但它与竞争对手相比如何？我们将根据其机构所有权、风险、收益、股息、分析师建议、盈利能力和估值的实力，将Akumin与相关业务进行比较。
Earnings & Valuation
收益与估值
This table compares Akumin and its rivals gross revenue, earnings per share and valuation.
下表比较了Akumin及其竞争对手的总收入、每股收益和估值。
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Akumin | $421.08 million | -$43.29 million | -1.55 |
| Akumin Competitors | $1.04 billion | $57.33 million | -0.03 |
| 总收入 | 净收入 | 市盈率 | |
| 阿库明 | 4.2108亿美元 | -4，329万元 | -1.55 |
| Akumin竞争对手 | 10.4亿美元 | 5733万美元 | -0.03 |
Akumin's rivals have higher revenue and earnings than Akumin. Akumin is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Akumin的竞争对手的收入和利润都高于Akumin。Akumin的市盈率低于竞争对手，这表明它目前比业内其他公司更便宜。
Analyst Ratings
分析师评级
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Akumin | 2 | 0 | 0 | 0 | 1.00 |
| Akumin Competitors | 136 | 718 | 1614 | 30 | 2.62 |
| 销售评级 | 保持评级 | 购买评级 | 强劲的买入评级 | 评级分数 | |
| 阿库明 | 2. | 0 | 0 | 0 | 1.00 |
| Akumin竞争对手 | 136 | 718 | 1614 | 30个 | 2.62 |
Akumin presently has a consensus target price of $0.63, indicating a potential downside of 62.35%. As a group, "Medical laboratories" companies have a potential upside of 98.20%. Given Akumin's rivals stronger consensus rating and higher possible upside, analysts plainly believe Akumin has less favorable growth aspects than its rivals.
Akumin目前的共识目标价为0.63美元，这表明潜在的下跌空间为62.35%。作为一个群体，“医学实验室”公司的潜在增长率为98.20%。鉴于Akumin的竞争对手更强的共识评级和更高的可能上行空间，分析师显然认为Akumin的增长方面不如竞争对手有利。
Institutional & Insider Ownership
机构与内部人持股
25.1% of Akumin shares are owned by institutional investors. Comparatively, 53.5% of shares of all "Medical laboratories" companies are owned by institutional investors. 17.0% of shares of all "Medical laboratories" companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
25.1%的Akumin股份由机构投资者持有。相比之下，所有“医学实验室”公司53.5%的股份由机构投资者拥有。所有“医学实验室”公司的17.0%的股份由公司内部人士拥有。强大的机构所有权表明，大型基金经理、捐赠基金和对冲基金认为，一家公司的长期表现将优于市场。
Volatility and Risk
波动性和风险
Akumin has a beta of 0.04, meaning that its share price is 96% less volatile than the S&P 500. Comparatively, Akumin's rivals have a beta of -1.65, meaning that their average share price is 265% less volatile than the S&P 500.
Akumin的贝塔系数为0.04，这意味着其股价的波动性比标准普尔500指数低96%。相比之下，Akumin的竞争对手的贝塔系数为-1.65，这意味着他们的平均股价波动性比标准普尔500指数低265%。
Profitability
盈利能力
This table compares Akumin and its rivals' net margins, return on equity and return on assets.
下表比较了Akumin及其竞争对手的净利润率、股本回报率和资产回报率。
| Net Margins | Return on Equity | Return on Assets | |
| Akumin | -14.16% | -29.00% | -3.87% |
| Akumin Competitors | -1,501.07% | -52.65% | -22.32% |
| 净利润率 | 股本回报率 | 资产回报率 | |
| 阿库明 | -14.16% | -29.00% | -3.87% |
| Akumin竞争对手 | -1，501.07% | -52.65% | -22.32% |
Summary
摘要
Akumin rivals beat Akumin on 8 of the 12 factors compared.
Akumin的竞争对手在12个因素中的8个方面击败了Akumin。
About Akumin
关于Akumin
(Get Rating)
(获取评级)
Akumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, digital radiography, fluoroscopy, and other diagnostic or interventional radiology procedures through a network of approximately 200 owned and/or operated imaging locations. It provides outpatient radiology, and oncology services and solutions to approximately 1,000 hospitals and health systems across 46 states. Akumin Inc. was founded in 2015 and is headquartered in Plantation, Florida.
Akumin Inc.在美国提供门诊诊断成像服务。它分为两个部分，放射学和肿瘤学。该公司提供各种医疗成像服务，包括磁共振成像，计算机断层扫描，正电子发射断层扫描，核医学，乳房X光检查，超声波，数字X线摄影，荧光透视，以及其他诊断或介入放射学程序通过网络约200拥有和/或经营的成像位置。它为46个州的约1，000家医院和卫生系统提供门诊放射学和肿瘤学服务和解决方案。Akumin Inc.成立于2015年，总部位于佛罗里达州种植园。
Receive News & Ratings for Akumin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akumin and related companies with MarketBeat.com's FREE daily email newsletter.
接受《Akumin Daily》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Akumin和相关公司的最新新闻和分析师评级的每日简要摘要。
